Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022;60(6):413-421.
doi: 10.5114/reum.2022.123671. Epub 2022 Dec 30.

Fibromyalgia syndrome: epidemiology, diagnosis and treatment

Burhan Fatih Kocyigit  1 , Ahmet Akyol  2
Affiliations

Fibromyalgia syndrome: epidemiology, diagnosis and treatment

Burhan Fatih Kocyigit et al. Reumatologia. 2022.

Abstract

Fibromyalgia syndrome (FMS) profoundly impacts patients' quality of life with its symptoms and clinical signs. Fibromyalgia syndrome impairs daily living activities, reduces work efficiency and raises health-related costs. Although the prevalence rates vary depending on geographical location and diagnostic criteria, it is a common disorder worldwide. Females have a higher prevalence of fibromyalgia syndrome, with varied rates, and there is an increase in prevalence rates with age. Although its etiopathogenesis has not been fully elucidated, various hypotheses have been proposed that central sensitization is at the core of the process. Fibromyalgia syndrome diagnostic approaches have advanced significantly over time, moving away from pain assessments alone and emphasizing multiple clinical signs of FMS. This condition has raised physicians' and researchers' awareness of non-pain symptoms. Considering the complicated etiopathogenesis of fibromyalgia syndrome, diverse pathways connected with symptoms, and multiple clinical presentations, it becomes clear that drug and non-drug treatments should be chosen in combination.

Keywords: diagnosis; epidemiology; fibromyalgia; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Fig. 1
Fig. 1
Epidemiology, diagnosis and treatment of fibromyalgia syndrome.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Offenbaecher M, Kohls N, Ewert T, et al. . Pain is not the major determinant of quality of life in fibromyalgia: results from a retrospective “real world” data analysis of fibromyalgia patients. Rheumatol Int 2021; 41: 1995–2006, DOI: 10.1007/s00296-020-04702-5. - DOI - PubMed
    1. Álvarez-Gallardo IC, Estévez-López F, Torres-Aguilar XC, et al. . Physical activity, sedentary behaviour, physical fitness, and cognitive performance in women with fibromyalgia who engage in reproductive and productive work: the al-Ándalus project. Clin Rheumatol 2019; 38: 3585–3593, DOI: 10.1007/s10067-019-04750-8. - DOI - PubMed
    1. Vincent A, Lahr BD, Wolfe F, et al. . Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project. Arthritis Care Res (Hoboken) 2013; 65: 786–792, DOI: 10.1002/acr.21896. - DOI - PMC - PubMed
    1. Ariani A, Bazzichi L, Sarzi-Puttini P, et al. . The Italian Society for Rheumatology clinical practice guidelines for the diagnosis and management of fibromyalgia Best practices based on current scientific evidence. Reumatismo 2021; 73: 89, DOI: 10.4081/reumatismo.2021.1362. - DOI - PubMed
    1. Siracusa R, Paola RD, Cuzzocrea S, Impellizzeri D. Fibromyalgia: pathogenesis, mechanisms, diagnosis and treatment options update. Int J Mol Sci 2021; 22: 3891, DOI: 10.3390/ijms22083891. - DOI - PMC - PubMed